MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) (L36155) Retirement - Effective October 11, 2026

Date Posted: August 27, 2026

This Local Coverage Determination (LCD) has been retired under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, NMI), and 01312 (NV).

Medicare Coverage Database (MCD) Number: L36155

Effective Date: October 11, 2026

Rationale:

This LCD is being superseded by MolDX: Genetic Testing for Hereditary Thrombophilia (L40242)

Visit the Retired LCDs webpage to access the retired LCDs.

Last Updated Aug 27 , 2026